Key facts
- This page summarizes Francisco Osvaldo Flores Garcia's Form 3 filing for TITAN PHARMACEUTICALS INC (TTNP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2024, 10:13.
Francisco Osvaldo Flores Garcia - 02 Apr 2024 Form 3 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)
- Reporting relationship
- Director
- Issuer ticker
- TTNP
- Reported as of
- 02 Apr 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Apr 2024, 10:13:26 UTC
- Next SEC filing
- 19 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Francisco Osvaldo Flores Garcia
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Francisco Osvaldo Flores Garcia filed Form 3 for TITAN PHARMACEUTICALS INC (TTNP) on 05 Apr 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTNP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 02 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
No securities are beneficially owned.